Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Buy ...

Our DNA is constantly under threat — from cell division errors to external factors like sunlight and smoking. Fortunately, ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

For the Liu Lab, necessity is truly the mother of invention. The researchers were examining how the 3D organization of the ...

This listicle explores four major RNA therapeutic modalities, highlighting their breakthroughs, challenges and future ...

Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) will likely be issuing its quarterly earnings data after the market ...

Researchers at The Jackson Laboratory and UConn Health discovered that cancer cells suppress "poison exons" — genetic ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

As we continue to advance our Axiomer ADAR-mediated RNA editing platform and pipeline, ProQR is entering a pivotal phase of growth and ...